<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 19-year-old male who suffered from severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> had been treated with granulocyte colony stimulating factor (G-CSF) from September 1991 </plain></SENT>
<SENT sid="1" pm="."><plain>Marked increase of hematopoietic cells in his bone marrow was observed, and maintenance administration of G-CSF was continued </plain></SENT>
<SENT sid="2" pm="."><plain>15 months later, myeloblasts with nuclear abnormality increased, and 22 months later, myeloblasts with chromosomal abnormality presenting 46, XY, -7, +21 exceeded 20%, and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> seemed to be transformed into <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> in T) </plain></SENT>
<SENT sid="3" pm="."><plain>The usefulness of G-CSF in the treatment of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> is now established, but there are some reports questioning the effect of long-term administration, especially transformation to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with <z:mp ids='MP_0004026'>monosomy</z:mp> 7 </plain></SENT>
<SENT sid="4" pm="."><plain>Leukemic transformation from <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> is very complex, but in some cases, long term administration of G-CSF may affect the natural course and may lead to the earlier development of <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
</text></document>